Veradigm | MDRX - الربح الإجمالي على المبيعات

سعر السهم
4.46
التغيير اليومي
-0.29 -6.11%
شهريا
4.21%
سنويا
3.72%
Q2 التوقعات
4.37




الربح الإجمالي على المبيعات تغيير تاريخ
Alcidion AUD 21.02M 5.65M 2025-12
Ambu A/S DKK 947M 68M 2025-12
Amplifon EUR 890.64M 787.47M 2025-12
Cardinal Health USD 2.5B 101M 2026-03
Centene USD 5.26B 3.12B 2026-03
Charles River Laboratories USD 279.32M 7.36M 2026-03
Cigna USD 6.08B 50.37B 2026-03
Coloplast 4.74B 27M 2025-12
Computer Programs Systems USD 35.62M 3.23M 2025-12
Convatec Group USD 660.5M 348.95M 2024-12
CVS Health USD 15.62B 2.06B 2026-03
Diasorin EUR 186M 4.92M 2025-12
Elevance Health USD 11.68B 889M 2025-12
General Electric Aerospace USD 4.24B 439M 2026-03
Gulf Medical Proj AED 46.22M 8.48M 2025-03
Humana USD 4.82B 754M 2025-06
IQVIA Holdings USD 1.07B 52M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Maximus USD 342.26M 23.59M 2026-03
McKesson USD 3.68B 143M 2025-12
Med Life RON 628.26M 7.99M 2025-09
Molina Healthcare USD 1.49B 292M 2026-03
Omnicell USD 140.36M 10.04M 2026-03
Oriola-kd EUR 40.2M 2.1M 2025-09
Owens Minor USD 272.05M 20.92M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Rede D'or Sao Luiz BRL 3.18B 176.73M 2025-12
Siemens Healthineers EUR 2.14B 66M 2026-03
Sonova Holding CHF 1.28B 205.2M 2025-12
Supermax Corporation Bhd MYR -143.15M 161.11M 2025-09
UnitedHealth USD 18.49B 2.14B 2025-12
Veeva Systems USD 622.47M 7.11M 2025-12
Veradigm USD 83.44M 3.95M 2022-09
Xerox USD 441M 15M 2025-06